主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IVVD
#2830
Invivyd, Inc. Common Stock
1.6
9
-1.17%
版块:
基础:
利润货币:
日范围
年范围
日变化
-1.17%
每月变动
-17.56%
6个月变化
+74.23%
年变化
+40.83%
前一天收盘价
1.7
1
Open
1.6
9
Bid
Ask
Low
1.6
9
High
1.6
9
交易量
53
市场
股票
医疗保健
IVVD
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
109.68 M
109.19 M
119.22 M
119.96 M
—
Valuation ratios
Enterprise value
—
77.17 M
234.52 M
-16.19 M
230.81 M
Price to earnings ratio
—
-0.7
-2.02
-0.31
-4
Price to sales ratio
—
—
—
2.07
8.73
Price to cash flow ratio
—
0.76
2.31
0.31
3.26
Price to book ratio
—
0.47
2.25
0.78
1.9
Enterprise value to EBITDA ratio
—
—
—
0.09
—
Profitability ratios
Return on assets %
0.37
0.63
0.87
1.31
0.54
Return on equity %
0.41
0.68
1.12
2.52
1.03
Return on invested capital %
5 741.96
699.99
622.46
3 936.81
937.02
Gross margin %
—
—
—
94.22
387.03
Operating margin %
—
—
—
696.8
500.58
EBITDA margin %
—
—
—
-702.58
—
Net margin %
—
—
—
669.42
481.68
Liquidity ratios
Quick ratio
—
—
—
1.21
4.88
Current ratio
9.94
15.06
4.47
1.62
6.95
Inventory turnover
—
—
—
0.06
0.06
Asset turnover
—
—
—
0.14
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
2.61
4.36
7.72
35.76
Long term debt to total equity ratio
—
2.81
5.63
14.81
67.39
Per share metrics
Operating cash flow per share
4.33
2.03
1.58
1.44
0.65
EBIT per share
—
—
—
-1.5
-0.48
EBITDA per share
—
—
—
-1.5
—
Total debt per share
—
—
—
—
—
Cash per share
12.72
0.85
1.83
0.58
1.78
Net current asset value per share
14.47
3.48
2.05
0.85
2.62
Tangible book value per share
13.09
3.29
1.62
0.57
1.92
Working capital per share
13.01
3.25
1.59
0.33
1.05
Book value per share
13.09
3.29
1.62
0.57
1.92
新闻
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Invivyd (IVVD) 首席人力资源官Green在期权行权后出售6.335万美元股票
Invivyd (IVVD) CHRO Green sells $63k in stock after option exercise
Invivyd首席科学官Allen出售价值58,600美元股票
Invivyd CSO Allen sells shares worth $58,600
Halozyme Therapeutics (HALO) Reports Q4 Loss, Tops Revenue Estimates
H.C. Wainwright 重申 Invivyd 股票买入评级,FDA 反馈引关注
H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback
Invivyd收到FDA关于COVID抗体与mRNA疫苗对比试验的反馈
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial
H.C. Wainwright 重申 Invivyd 股票买入评级,关键试验数据即将公布